RESEARCH ARTICLE
Use of a Thrombin Fibrin Sealant in Reducing Blood Loss in Revision Hip Arthroplasty
Ali Ghoz 1, Hesham Al-Khateeb*, 2, Shanmugasundaram Rajkumar 2, Shawn Tavares 3, Antonio Andrade 3
Article Information
Identifiers and Pagination:
Year: 2015Volume: 9
Issue: Suppl 2: M10
First Page: 511
Last Page: 514
Publisher ID: TOORTHJ-9-511
DOI: 10.2174/1874325001509010511
Article History:
Received Date: 24/2/2015Revision Received Date: 31/5/2015
Acceptance Date: 3/5/2015
Electronic publication date: 5/10/2015
Collection year: 2015
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Abstract
We present a retrospective evaluation assessing the use of a novel fibrin sealant, Quixil® (OMRIX Biopharmaceuticals S.A.) in reducing blood transfusions following revision total hip replacement surgery. Forty four patients underwent revision total hip replacement surgery using Quixil®, while 45 patients underwent revision total hip replacement surgery without the use of Quixil®. The duration of surgery and patient demographics were similar in both groups. Average blood loss was 1,010ml in the Quixil® group versus 1,021ml in the non-Quixil group. The use of cell saver and intra-operative blood transfusion were similar in both groups. The mean pre-operative Haemoglobin was 13.0 g/dl in the Quixil® group versus 12.4 g/dl in the non-Quixil group. The mean post-operative haemoglobin was 10.2 g/dl and 9.1 g/dl in the Quixil® and non-Quixil groups respectively. There was no difference in the blood transfused post-operatively between the two groups. Total units of blood transfused in Quixil®versus non-Quixil group were 60 verus 86. Total units of intra-operative blood transfused in Quixil®versus non-Quixil group were 16 versus 23. The use of fibrin tissue adhesive in revision total hip arthroplasty seems to be an effective and reliable means to reduce blood-transfusion requirements and prevent post-operative decreases in hemoglobin.
